The trials listed below are accepting new patients.  Interested patients can Email the coordinator by clicking on envelope icon. Please include a phone number and best times to call.

Treatment stage
Protocol Title 
ClinicalTrials.Gov Link
Penn Research Coordinator 
Am I Eligible?

MYTHIC: Phase 1 Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients with Advanced Solid Tumors

NCT4855656 Andrea Standish, RN Eligibility Criteria 
Recurrent ATRN: A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral ATRN-119 in Patients with Advanced Solid Tumors NCT04905914 Andrea Standish, RN  Eligibility Criteria
Recurrent Xencor: A Phase 2 Study of XmAb®20717 in Patients With Selected Gynecological Malignancies and High-Risk Metastatic Castration-Resistant Prostate Cancer NCT05032040 Isabel Forbes Eligibility Criteria
Recurrent NP-G2-044-P2-01: NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies NCT05023486 Shavon Rochester Eligibility Criteria
Primary Radiation

GynWPProton: Whole Pelvis Proton Radiation for Gynecologic Cancer

NCT05758688 Kelly Clark Eligibility Criteria
Surgery GOG 3043: A Randomized Controlled Trial of Robotic versus Open Radical Hysterectomy for Cervical Cancer
(ROCC trial)
NCT04831580 Destany Fields Eligibility Criteria